Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1313

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 5
Chunk 1313
---
, 2024 until exercised in full. The January
2024 Warrants have an exercise price of $25.41 per share and are exercisable beginning on January 31, 2024 until January 31, 2029. 

The Company granted WallachBeth Capital LLC a
45-day over-allotment option to purchase up to 13,153 shares of the Company’s common stock at a price of $23.10 per share and/or
15,650 January 2024 Warrants at a price of $0.60 per warrant and/or 2,498 January 2024 Pre-Funded Warrants at a price of $22.50 per pre-funded
warrant, or any combination thereof, in all cases less the underwriting discount. WallachBeth Capital LLC partially exercised its over-allotment
option with respect to 13,637 January 2024 Warrants on January 31, 2024, and purchased an additional one share of common stock at a purchase
price of $22.50 per share and one January 2024 Warrant at a purchase price of $0.60 per warrant on February 14, 2024.

The Company also issued to WallachBeth Capital
LLC warrants (the “January 2024 Representative Warrants”) to purchase 6,260 shares of the Company’s common stock at
an exercise price of $25.41 per share. The January 2024 Representative Warrants are exercisable beginning on January 31, 2024 until January
31, 2029.

The units and pre-funded units were offered
and sold pursuant to the Company’s Registration Statement on Form S-1 (File No. 333-276641), declared effective by the SEC on
January 29, 2024. The closing of the January 2024 Offering occurred on January 31, 2024, generating net proceeds to the Company of
approximately $1.9 million, after deducting underwriting discounts and commissions and the payment of other offering expenses
payable by the Company of approximately $510,000.

On February 1, 2024 and April 9, 2024, the Company
issued 8,326 shares and 8,326 shares of common stock, respectively upon the exercise of 8,326 and 8,326 January 2024 Pre-Funded Warrants,
respectively, resulting in aggregate proceeds to the Company of $9,990.

On April 1